Arrowhead Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Pasadena, CA
ARWR chart
What traders are saying about $ARWR
Latest postsArrowhead Pharmaceuticals, Inc. news
- FMR LLC Adds Arrowhead Pharmaceuticals Inc (ARWR) Shares -- Stock Looks 8% Overvalued on GF Value
GuruFocus ·
- ARWR Stock On Track To Hit Over 5-Year Highs – Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval
Stocktwits ·
- PepGen Stock Spikes 132% on Rare-Disease Win. These Rivals Are Feeling The Pressure.
Yahoo Finance ·
- B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $123
Moomoo ·
- Is Arrowhead Pharmaceuticals (ARWR) Worth Its Price After UK Approval?
Yahoo Finance ·
- Understanding Momentum Shifts in (ARWR)
Stock Traders Daily ·
- Mid-cap biotech catalysts: FDA dates, earnings, and pipeline data to watch
Yahoo Finance ·
- Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- What Do Arrowhead Pharmaceuticals (ARWR) New AHA Trial Results Change?
Simply Wall St ·
- $ARWR stock is down 15% today. Here's what we see in our data.
Quiver Quantitative ·
- Arrowhead Pharmaceuticals Inc.R (HDP1.HA) Q2 FY2026 earnings call transcript
Yahoo Finance ·
- Arrowhead Pharmaceuticals Inc (HDP1.HA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
Arrowhead Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $829.4M | $3.6M | $240.7M | $243.2M |
| Net income | -$1.6M | -$599.5M | -$205.3M | -$176.1M |
| Diluted EPS | $-0.01 | $-5.00 | $-1.92 | $-1.67 |
| Total assets (year end) | $1.60B | $1.01B | $626.3M | $891.5M |
| Cash and equivalents (year end) | – | – | $58.2M | $202.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arrowhead Pharmaceuticals, Inc.
- Ticker
- ARWR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Pasadena, CA
- Incorporated in
- DE
- Fiscal year end
- September 30
- SEC CIK
- 879407
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Frequently asked questions
What exchange is Arrowhead Pharmaceuticals, Inc. listed on?
Arrowhead Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ARWR.
What industry is Arrowhead Pharmaceuticals, Inc. in?
Arrowhead Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arrowhead Pharmaceuticals, Inc. headquartered?
Arrowhead Pharmaceuticals, Inc.'s business address on file with the SEC is in Pasadena, CA.
When does Arrowhead Pharmaceuticals, Inc.'s fiscal year end?
Arrowhead Pharmaceuticals, Inc.'s fiscal year ends on September 30.
How much revenue did Arrowhead Pharmaceuticals, Inc. report?
Arrowhead Pharmaceuticals, Inc. reported $829.4M in revenue for calendar year 2025, according to its SEC filings.